2011•PubMedRequires access

[The study of CD4+ and CD8+ T subsets in chronic hepatitis B patients].

Xuehua Sun, Qiao-li Liu, Man Li, Yueqiu Gao

Open publisher page 1 citations

Abstract

AIM: To investigate the difference of CD4+ and CD8+ T subsets in different infection status of chronic hepatitis B (CHB) patients. METHODS: 13 Healthy people were chosen as control group. According to infection status, 78 CHB patients were sorted into HBeAg(+) and normal liver function group, HBeAg(+) and abnormal liver function group, and HBeAg(-) group. The percentages of some subsets of CD4+T and CD8+T cells in CHB patients and healthy people were examined by Flow cytometer, and the correlations between the subsets of T cells and the HBVDNA levels and HBeAg were analyzed. RESULTS: As compared with control group, the percentages of CD4+CD25+/CD4+ and CD4+CD95+/CD4+ were increased (P<0.01, P<0.05) in HBeAg(+) and normal liver function group, and the percentages of CD8+CD28-/CD8+ in three patients groups were increased (P<0.01). As compared with the HBeAg(+) and normal liver function group, the percentages of CD4+CD25+/CD4+ in HBeAg(+) and abnormal liver function group, and HBeAg(-) group were decreased (P<0.01), and the percentages of CD8+CD95+/CD8+ in HBeAg(-) group and the percentages of CD8+CD95+/CD8 in HBeAg(+) and abnormal liver function group were decreased (P<0.05, P<0.01). Moreover, there were positive correlations between CD4+CD25+/CD4+, CD4+CD95+/CD4+ and the HBVDNA levels(P<0.01); there were inverse correlations between CD4+CD28+/CD4+ and the HBVDNA levels and HBeAg (P<0.05, P<0.01); there were positive correlations between CD8+CD28-/CD8+ and HBVDNA and HBeAg (P<0.01). CONCLUSION: Some T cell Subsets, including CD4+CD25+, CD4+CD95+ , and CD8+CD28-, are increased in CHB patients, which maybe play some roles in the immune tolerance of chronic HBV infection.

About this research paper

What this paper is about

AIM: To investigate the difference of CD4+ and CD8+ T subsets in different infection status of chronic hepatitis B (CHB) patients. METHODS: 13 Healthy people were chosen as control group. According to infection status, 78 CHB patients were sorted into HBeAg(+) and normal liver function group, HBeAg(+) and abnormal liver function group, and HBeAg(-) group. The percentages of some subsets of CD4+T and CD8+T cells in CHB patients and healthy people were examined by Flow cytometer, and the correlations between the subsets of T cells and the HBVDNA levels and HBeAg were analyzed. RESULTS: As compared with control group, the percentages of CD4+CD25+/CD4+ and CD4+CD95+/CD4+ were increased (P<0.01, P<0.05) in HBeAg(+) and normal liver function group, and the percentages of CD8+CD28-/CD8+ in three patients groups were increased (P<0.01). As compared with the HBeAg(+) and normal liver function group, the percentages of CD4+CD25+/CD4+ in HBeAg(+) and abnormal liver function group, and HBeAg(-) group were decreased (P<0.01), and the percentages of CD8+CD95+/CD8+ in HBeAg(-) group and the percentages of CD8+CD95+/CD8 in HBeAg(+) and abnormal liver function group were decreased (P<0.05, P<0.01). Moreover, there were positive correlations between CD4+CD25+/CD4+, CD4+CD95+/CD4+ and the HBVDNA levels(P<0.01); there were inverse correlations between CD4+CD28+/CD4+ and the HBVDNA levels and HBeAg (P<0.05, P<0.01); there were positive correlations between CD8+CD28-/CD8+ and HBVDNA and HBeAg (P<0.01). CONCLUSION: Some T cell Subsets, including CD4+CD25+, CD4+CD95+ , and CD8+CD28-, are increased in CHB patients, which maybe play some roles in the immune tolerance of chronic HBV infection.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To investigate the difference of CD4+ and CD8+ T subsets in different infection status of chronic hepatitis B (CHB) patients. METHODS: 13 Healthy people were chosen as control group. According to infection status, 78 CHB patients were sorted into HBeAg(+) and normal liver function group, HBeAg(+) and abnormal liver function group, and HBeAg(-) group. The percentages of some subsets of CD4+T and CD8+T cells in CHB patients and healthy people were examined by Flow cytometer, and the correlations between the subsets of T cells and the HBVDNA levels and HBeAg were analyzed. RESULTS: As compared with control group, the percentages of CD4+CD25+/CD4+ and CD4+CD95+/CD4+ were increased (P<0.01, P<0.05) in HBeAg(+) and normal liver function group, and the percentages of CD8+CD28-/CD8+ in three patients groups were increased (P<0.01). As compared with the HBeAg(+) and normal liver function group, the percentages of CD4+CD25+/CD4+ in HBeAg(+) and abnormal liver function group, and HBeAg(-) group were decreased (P<0.01), and the percentages of CD8+CD95+/CD8+ in HBeAg(-) group and the percentages of CD8+CD95+/CD8 in HBeAg(+) and abnormal liver function group were decreased (P<0.05, P<0.01). Moreover, there were positive correlations between CD4+CD25+/CD4+, CD4+CD95+/CD4+ and the HBVDNA levels(P<0.01); there were inverse correlations between CD4+CD28+/CD4+ and the HBVDNA levels and HBeAg (P<0.05, P<0.01); there were positive correlations between CD8+CD28-/CD8+ and HBVDNA and HBeAg (P<0.01). CONCLUSION: Some T cell Subsets, including CD4+CD25+, CD4+CD95+ , and CD8+CD28-, are increased in CHB patients, which maybe play some roles in the immune tolerance of chronic HBV infection.

Key concepts: CD8, HBeAg, Chronic hepatitis, Gastroenterology, Medicine, Lymphocyte subsets, Liver function, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
[The study of CD4+ and CD8+ T subsets in chronic hepatitis B patients]. — Research Paper | ScholarLens